Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Gilead Sciences, Inc. (GILD) stock news and headlines to help you in your trading and investing decisions.

Interactive Chart for Gilead Sciences, Inc. (GILD), analyze all the data with a huge range of indicators.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Gilead Sciences (GILD) closed the latest trading day at $71.64, indicating a +1.17% change from the previous session's end. This change outpaced the S&P 500's 0.64% gain on the day.

Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly format back to when Gilead Sciences, Inc. stock was issued.

Biotech giant Gilead Sciences, Inc. GILD is scheduled to report third-quarter 2024 results on Nov. 6, after market close.

See Gilead Sciences, Inc. (GILD) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Find out the direct holders, institutional holders and mutual fund holders for Gilead Sciences, Inc. (GILD).

Gilead Sciences increased its growth forecast for the year on strong third quarter results, marking a shift away from its COVID revenues and spurring investor anticipation for new products in the ...